The introduction of nicotinamide being a nicotine substitution in e-cigarette and smokeless goods represents a significant regulatory challenge with the FDA. Nicotinamide does not have nicotinic receptor agonist exercise and is understood to act as a sedative at large dosages6. The promises created by Nicotine River, ECBlend, as well as other suppl